SLCTR/2023/012尚未招募3 期
Impact of the SGLT2 inhibitor, empagliflozin on nephrolithiasis among non diabetes: a randomized, double-blind, placebo-controlled trial.
Professorial Medical Unit0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Both male and female
- •Minimum age- 18 yrs
- •Maximum age- 75 yrs.
- •Having renal parenchymal and pelvicalyceal stones
- •With kidney stone with the size of more than four millimeters on abdominal CT scan
排除标准
- •* Size less than four millimetre stones in the kidney
- •* Having ureteric stones
- •* Having known allergy to study drug
- •* eGFR less than 30 m2,
- •* Pregnant women
- •* Lactating women
- •* Kidney transplant patients
研究者
相似试验
招募中
2 期
Effect of SGLT2 Inhibition With Empagliflozin on Atrial Fibrillation Severity (SWEET-AF)Cardiovascular - Other cardiovascular diseasesAtrial FibrillationACTRN12621000208808The University of Adelaide300
进行中（未招募）
1 期
To investigate whether treatment with the SGLT-2 inhibitor dapagliflozin improves the perception of hypoglycemia in people with type 1 diabetes with impaired awareness of hypoglycemiaType 1 diabetesEUCTR2018-001569-17-NLRadboud university medical center15
已完成
2 期
Effect of the SGLT-2 inhibitor dapagliflozine on impaired awareness of hypoglycemia in type 1 diabetesImpaired Awareness of Hypoglycemiahypoglycemia unawareness10018424DiabetesNL-OMON48616Radboud Universitair Medisch Centrum15
进行中（未招募）
1 期
SGLT2 inhibition with empagliflozin in patients with type 2 diabetes mellitus: Influences on left ventricular mass, function, and lipid content of myocardium (EMPATROPHY)Patients with type 2 diabetes mellitus on background metformin treatment.MedDRA version: 18.0Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-003313-28-DEHannover Medical School60
进行中（未招募）
1 期
Empagliflozin reduces progression of diabetic retinopathy in patients with high risk of diabetic macular edemaEUCTR2016-000825-38-DEHannover Medical School80